YAP1 and osteosarcoma: A novel small molecule YAP inhibitor, CA3, has demonstrated the potential to inhibit tumor growth in multiple cancers, including esophageal adenocarcinoma, pancreatic cancer, and osteosarcoma.148, 149, 150